ACQUISITIONS - Sarif Biomedical (Details) - Sarif Biomedical, LLC |
1 Months Ended | 12 Months Ended | |
|---|---|---|---|
|
May 02, 2014
USD ($)
payment
|
Sep. 30, 2014
USD ($)
|
Dec. 31, 2016
USD ($)
|
|
| Acquisitions | |||
| Ownership Interest Controlling Owners | 100.00% | ||
| Number of cash payments made | payment | 2 | ||
| Consideration paid | $ 550,000 | $ 552,024 | |
| Maximum possible amount of future payments | 250,000,000 | ||
| Promissory note issued | 250,000 | ||
| Promissory note amount upon late payment | $ 300,000 | ||
| Payment agreement to extend maturity date | $ 26,250 | ||
| Note term | 30 days |
| X | ||||||||||
- Definition Represents the number of cash payments made as part of a business acquisition. No definition available.
|
| X | ||||||||||
- Definition The possible fair value of a note issued contingent on the occurrence of agreed-upon events. No definition available.
|
| X | ||||||||||
- Definition The equity interest of controlling shareholders, partners or other equity holders in an entity. No definition available.
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
| X | ||||||||||
- Definition For contingent consideration arrangements recognized in connection with a business combination, this element represents an estimate of the high-end of the potential range (undiscounted) of the consideration which may be paid. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. No definition available.
|
| X | ||||||||||
- Definition Carrying amount as of the balance sheet date of obligations due all related parties. For classified balance sheets, represents the current portion of such liabilities (due within one year or within the normal operating cycle if longer). Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition The fair value of notes issued in noncash investing and financing activities. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Details
|